Homepage
Medication Guide
What Are the Purchase Channels for Binimetinib (Mektovi)?
Binimetinib (Mektovi) is an important MEK inhibitor that plays a key role in the treatment of melanoma and lung cancer. As this medication is a prescription drug and related to significant health and ...
511
Monday, December 1st, 2025, 09:55
What are the Indications of Binimetinib (Mektovi)?
Binimetinib (Mektovi) is a highly potent and selective mitogen-activated protein kinase (MEK) inhibitor that plays a crucial role in the field of cancer treatment. As a molecular targeted therapy drug...
507
Monday, December 1st, 2025, 09:44
Side Effects of Lomitapide (Juxtapid)
Lomitapide (Juxtapid) is a microsomal triglyceride transfer protein (MTP) inhibitor, primarily indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). Although this medication ...
512
Monday, December 1st, 2025, 09:28
What are the Precautions for Lomitapide (Juxtapid) Use?
Lomitapide (Juxtapid) is a novel microsomal triglyceride transfer protein inhibitor, indicated as an adjunctive therapy for homozygous familial hypercholesterolemia. Its unique mechanism of action and...
509
Monday, December 1st, 2025, 09:19
Dosage and Administration, Recommended Dosage of Juxtapid (Lomitapide)
Juxtapid (lomitapide) is a microsomal triglyceride transfer protein inhibitor specifically indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). As a potent lipid-lowering dr...
510
Friday, November 28th, 2025, 11:07
What Are the Indications of Juxtapid (Lomitapide)?
Juxtapid (lomitapide) is an innovative lipid-lowering drug. As a microsomal triglyceride transfer protein inhibitor, it is specifically indicated for the treatment of specific types of hypercholestero...
507
Friday, November 28th, 2025, 11:00
What Are the Purchase Channels for Juxtapid (Lomitapide)?
Juxtapid (lomitapide) is a prescription medication specifically indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). Extra caution is required for its purchase and use.What ...
508
Friday, November 28th, 2025, 10:45
How to Use Vonjo (Pacritinib)
Vonjo (pacritinib) is an oral kinase inhibitor approved by the U.S. FDA in 2022. It is specifically indicated for the treatment of adult patients with intermediate- or high-risk primary or secondary (...
511
Friday, November 28th, 2025, 10:41
What is Vonjo (Pacritinib)?
Vonjo (pacritinib) is a novel kinase inhibitor approved by the U.S. Food and Drug Administration (FDA), providing a new treatment option for patients with specific types of myelofibrosis.What is Vonjo...
514
Friday, November 28th, 2025, 10:21
How to Purchase Vonjo (Pacritinib)
Vonjo (pacritinib) is a prescription medication for patients with specific types of myelofibrosis. Its purchase and use must strictly comply with medical regulations.How to Purchase Vonjo (Pacritinib)...
509
Friday, November 28th, 2025, 10:17
48 / 214
2139 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved